Related references
Note: Only part of the references are listed.AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset
David Goertsen et al.
NATURE NEUROSCIENCE (2022)
Rare coding variants in ten genes confer substantial risk for schizophrenia
Tarjinder Singh et al.
NATURE (2022)
Overcoming innate immune barriers that impede AAV gene therapy vectors
Manish Muhuri et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Crossing the blood-brain barrier with AAV vectors
Dan Liu et al.
METABOLIC BRAIN DISEASE (2021)
Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors
Josephine Macdonald et al.
HUMAN GENE THERAPY (2021)
Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue
Gretchen Thomsen et al.
NATURE MEDICINE (2021)
Deep diversification of an AAV capsid protein by machine learning
Drew H. Bryant et al.
NATURE BIOTECHNOLOGY (2021)
Risdiplam in Type 1 Spinal Muscular Atrophy
Giovanni Baranello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning
Mathieu Nonnenmacher et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice
Sarah E. Sinnett et al.
BRAIN (2021)
Nonsense suppression therapies in human genetic diseases
Patricia Martins-Dias et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
Behrang Mahjani et al.
MOLECULAR AUTISM (2021)
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W. Day et al.
LANCET NEUROLOGY (2021)
Presymptomatic training mitigates functional deficits in a mouse model of Rett syndrome
Nathan P. Achilly et al.
NATURE (2021)
Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction
Manish Muhuri et al.
FRONTIERS IN IMMUNOLOGY (2021)
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
Mohammadsharif Tabebordbar et al.
CELL (2021)
Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
Kandamurugu Manickam et al.
GENETICS IN MEDICINE (2021)
A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system
Oleksandr Kondratov et al.
MOLECULAR THERAPY (2021)
Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary
Jill A. Morris et al.
MOLECULAR THERAPY (2021)
Exome sequencing in obsessive-compulsive disorder reveals a burden of rare damaging coding variants
Mathew Halvorsen et al.
NATURE NEUROSCIENCE (2021)
Discovery and implications of polygenicity of common diseases
Peter M. Visscher et al.
SCIENCE (2021)
AAV ablates neurogenesis in the adult murine hippocampus
Stephen Johnston et al.
ELIFE (2021)
Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
Paul E. Monahan et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Regulated control of gene therapies by drug-induced splicing
Alex Mas Monteys et al.
NATURE (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model
Tom Willgoss et al.
CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2021)
dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice
Gaia Colasante et al.
MOLECULAR THERAPY (2020)
De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism
Carolina Cappi et al.
BIOLOGICAL PSYCHIATRY (2020)
A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna
Toloo Taghian et al.
MOLECULAR THERAPY (2020)
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism
F. Kyle Satterstrom et al.
CELL (2020)
Codon Modification and PAMPs in Clinical AAV Vectors: The Tortoise or the Hare?
J. Fraser Wright
MOLECULAR THERAPY (2020)
Engineering adeno-associated virus vectors for gene therapy
Chengwen Li et al.
NATURE REVIEWS GENETICS (2020)
Angelman Syndrome: From Mouse Models to Therapy
Diana C. Rotaru et al.
NEUROSCIENCE (2020)
Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases
Barbara A. Perez et al.
BRAIN SCIENCES (2020)
Re: Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy by Wilson and Flotte
Perry B. Shieh et al.
HUMAN GENE THERAPY (2020)
Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy
James M. Wilson et al.
HUMAN GENE THERAPY (2020)
Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies
Alexander J. Sandweiss et al.
LANCET NEUROLOGY (2020)
SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS
Christian Mueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Neurodevelopmental Disorders: From Genetics to Functional Pathways
Ilaria Parenti et al.
TRENDS IN NEUROSCIENCES (2020)
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
Kian Huat Lim et al.
NATURE COMMUNICATIONS (2020)
In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing
John R. Sinnamon et al.
CELL REPORTS (2020)
AAV9-Retro mediates efficient transduction with axon terminal absorption and blood-brain barrier transportation
Kunzhang Lin et al.
MOLECULAR BRAIN (2020)
Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates
Douglas J. Ballon et al.
HUMAN GENE THERAPY (2020)
MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates
Juliette Hordeaux et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Identification of common genetic risk variants for autism spectrum disorder
Jakob Grove et al.
NATURE GENETICS (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Rational Design of Gene Therapy Vectors
Dao Pan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
Siddharth Srivastava et al.
GENETICS IN MEDICINE (2019)
Recessive gene disruptions in autism spectrum disorder
Ryan N. Doan et al.
NATURE GENETICS (2019)
Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort
Dan Bai et al.
JAMA PSYCHIATRY (2019)
Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variants
F. Kyle Satterstrom et al.
NATURE NEUROSCIENCE (2019)
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Pierce J. Ogden et al.
SCIENCE (2019)
A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism
Marcus Davidsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity
Yuanyuan Xiao et al.
JCI INSIGHT (2019)
Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum
Andrea Ganna et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
X-linked intellectual disability update 2017
Giovanni Neri et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
Christian Hinderer et al.
HUMAN GENE THERAPY (2018)
Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
Yonghong Chen et al.
MOLECULAR THERAPY (2018)
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
Nicole K. Paulk et al.
MOLECULAR THERAPY (2018)
Standardized Method for Intra-Cisterna Magna Delivery Under Fluoroscopic Guidance in Nonhuman Primates
Nathan Katz et al.
HUMAN GENE THERAPY METHODS (2018)
A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates
Dan Wang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques
Juliette Hordeaux et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Synergistic and independent action of endogenous microRNAs 122a and 199a for post-transcriptional liver detargeting of gene vectors
Bijay Dhungel et al.
SCIENTIFIC REPORTS (2018)
Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors
Peter T. Tsai et al.
CELL REPORTS (2018)
Development of a patient-centered conceptual model of the impact of living with autism spectrum disorder
Fiona McDougall et al.
AUTISM (2018)
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
Christian R. Marshall et al.
NATURE GENETICS (2017)
Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution
Dirk Grimm et al.
HUMAN GENE THERAPY (2017)
A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear
Lukas D. Landegger et al.
NATURE BIOTECHNOLOGY (2017)
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability
Tarjinder Singh et al.
NATURE GENETICS (2017)
Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders
Daniel J. Weiner et al.
NATURE GENETICS (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration
Jessica L. Cohen-Pfeffer et al.
PEDIATRIC NEUROLOGY (2017)
Dosage sensitivity is a major determinant of human copy number variant pathogenicity
Alan M. Rice et al.
NATURE COMMUNICATIONS (2017)
Lessons from ten years of genome-wide association studies of asthma
Cristina T. Vicente et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Glymphatic MRI in idiopathic normal pressure hydrocephalus
Geir Ringstad et al.
BRAIN (2017)
10 Years of GWAS Discovery: Biology, Function, and Translation
Peter M. Visscher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Heritability of autism spectrum disorders: a meta-analysis of twin studies
Beata Tick et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2016)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII
Brittney L. Gurda et al.
MOLECULAR THERAPY (2016)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery
Haiyan Fu et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice
Vera Lukashchuk et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model
Sara Silva-Santos et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Linyan Meng et al.
NATURE (2015)
Synaptic, transcriptional and chromatin genes disrupted in autism
Silvia De Rubeis et al.
NATURE (2014)
Most genetic risk for autism resides with common variation
Trent Gaugler et al.
NATURE GENETICS (2014)
Biology of adeno-associated viral vectors in the central nervous system
Giridhar Murlidharan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Angelman syndrome: review of clinical and molecular aspects
Lynne M. Bird
APPLICATION OF CLINICAL GENETICS (2014)
Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
S. J. Gray et al.
GENE THERAPY (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting
Catalina Betancur
BRAIN RESEARCH (2011)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression
Jun Xie et al.
MOLECULAR THERAPY (2011)
Child and adolescent psychiatric genetics
Johannes Hebebrand et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2010)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy
Yong Hong Chen et al.
NATURE MEDICINE (2009)
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state
Brian D. Brown et al.
NATURE BIOTECHNOLOGY (2007)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Long-term pharmacologically regulated expression of erythropoietin in,primates following AAV-mediated gene transfer
VM Rivera et al.
BLOOD (2005)
Spinal CSF absorption in healthy individuals
M Edsbagge et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Share Paper
